(Q73395687)
Statements
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer (English)
M S Gordon
K Margolin
M Talpaz
G W Sledge
E Holmgren
R Benjamin
S Stalter
S Shak